Browse by author
Lookup NU author(s): Professor Linda Sharp
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© 2018 Springer Science+Business Media, LLC, part of Springer Nature Purpose: We examined whether demographic and tumour characteristics (including subtype) were different for women with breast cancer diagnosed via mammography screening compared with women with interval breast cancers, lapsed attenders of the screening programme and non-participants of the screening programme. In addition, we explored whether there were survival differences between the groups, taking into account lead time bias. Methods: We used linked data from National Cancer Registry Ireland and the national breast screening programme BreastCheck. Multinomial logistic regression was used to test the association of covariates with screening status. For survival analysis, we corrected the survival time for screen-detected cases for lead time bias, examined Kaplan–Meier curves and then used Cox regression to investigate differences in survival by screening status. Results: Subtype (HER2 over-expressing, triple negative), stage (III/IV), grade (poor), having co-morbidities, area of deprivation, smoking status and age were associated with having interval cancer or being a non-participant of the screening programme in the multivariable model. After correcting for lead time bias, and adjusting for variables associated with screening status, there was no evidence that risk of breast-cancer death for women with screen-detected cancer was different from women with interval cancer (HR = 0.76, 95% CI 0.56–1.03), non-participants (HR = 1.07, 95% CI 0.84–1.37) and lapsed attenders (HR = 0.97, 95% CI 0.65–1.45). Conclusions: Screening status was strongly associated with subtype and this association persisted after adjustment for covariates including tumour stage and grade. After correcting for lead-time bias and adjusting for stage, subtype, grade and socio-demographic variables, no significant survival difference was demonstrated for women with screen-detected cancer in the 5-year period post-diagnosis. Since we are adjusting for stage, subtype and other variables, the lack of difference between these groups would be expected but has not been demonstrated in studies which do not correct for lead time bias.
Author(s): O'Brien KM, Mooney T, Fitzpatrick P, Sharp L
Publication type: Article
Publication status: Published
Journal: Breast Cancer Research and Treatment
Year: 2018
Volume: 172
Issue: 1
Pages: 133-142
Print publication date: 01/11/2018
Online publication date: 13/07/2018
Acceptance date: 31/05/2018
ISSN (print): 0167-6806
ISSN (electronic): 1573-7217
Publisher: Springer New York LLC
URL: https://doi.org/10.1007/s10549-018-4877-9
DOI: 10.1007/s10549-018-4877-9
Altmetrics provided by Altmetric
